Muhammad Khurram Guhjjar, MD
Nephrology · Omaha, NENPI 1962854307
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for nephrology clinicians in NE, where the typical reported total is $1,214.
Across 14 payments — averaging $21.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fresenius USA Marketing, Inc.$56
- Calliditas Therapeutics US Inc.$54
- Boehringer Ingelheim$53
- Otsuka America Pharmaceutical, Inc.$41
- Sanofi$36
- Mallinckrodt Hospital Products Inc.$25
- plus $35 from 2 others
What the payments were for
- Food & beverage$301100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fresenius USA Marketing, Inc. | 3 | $56 |
| Calliditas Therapeutics US Inc. | 2 | $54 |
| Boehringer Ingelheim | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Sanofi | 1 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Vifor Pharma, Inc. | 1 | $21 |
| AstraZeneca | 1 | $14 |
How this compares
$301 in reported general payments places this provider in the 25th percentile of 60 nephrology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Omaha
- Richard LundOmaha$378K
- Jeffrey PasserOmaha$146K
- Roslyn MannonOmaha$64K
- Troy PlumbOmaha$17K
- Eric MagliuloOmaha$9K
- Prasanth RavipatiOmaha$7K
- Joseph BastOmaha$5K
- Stefan HemmingsOmaha$5K
- Sunil JagadeshOmaha$4K
- Judd BauerOmaha$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.